FISCHBEIN v. IQVIA, INC.

CourtDistrict Court, E.D. Pennsylvania
DecidedJune 5, 2025
Docket2:19-cv-05365
StatusUnknown

This text of FISCHBEIN v. IQVIA, INC. (FISCHBEIN v. IQVIA, INC.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
FISCHBEIN v. IQVIA, INC., (E.D. Pa. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

RICHARD E. FISCHBEIN, M.D., : CIVIL ACTION Individually and as the : Representative of a Class of Similarly : NO. 19-5365 Situated Persons, : Plaintiff : NO. 21-1334 : v. : : IQVIA, INC. : Defendant :

NITZA I. QUIÑONES ALEJANDRO, J. JUNE 5, 2025

MEMORANDUM OPINION

INTRODUCTION Plaintiff Richard E. Fischbein, M.D. (“Plaintiff”) filed this class action against Defendant IQVIA, Inc. (“Defendant”), asserting that Defendant violated the Telephone Consumer Protection Act, 47 U.S.C. § 227(b)(1)(C), when sending Plaintiff and other purportedly similarly situated healthcare provider class members unsolicited fax advertisements without prior express invitation or permission. Before this Court are Plaintiff’s motion for class certification filed pursuant to Federal Rule of Civil Procedure (“Rule”) 23, (ECF 87, 89), and Defendant’s response, (ECF 92, 95). The motion for class certification is now ripe for disposition. For the reasons set forth, the motion for class certification is denied. BACKGROUND The Telephone Consumer Protection Act (the “TCPA”) provides that “[i]t shall be unlawful for any person within the United States, or any person outside the United States if the recipient is within the United States . . . to use any telephone facsimile machine, computer, or other device to send, to a telephone facsimile machine, an unsolicited advertisement . . . .” 47 U.S.C. § 227(b)(1)(C). Under the TCPA, an “unsolicited advertisement” is “any material advertising the commercial availability or quality of any property, goods, or services which is transmitted to any person without that person’s prior express invitation or permission, in writing or otherwise.” Id. at § 227(a)(5).

Here, Plaintiff asserts that Defendant violated the TCPA by faxing mass advertisements to Plaintiff and a class of purportedly more than 25,000 healthcare providers without obtaining prior express invitation or permission. The facts relevant to class certification are summarized as follows:1 Defendant is a research organization that provides services, such as clinical trial monitoring and data management, to clients in the health information industry. Defendant’s business includes the collection of human health data for clients and to augment its own commercial databases. Defendant obtains its data by, inter alia, sending faxes to medical providers encouraging them to share information about their patients and treatment practices.

Plaintiff is a physician who received at least two such faxes from Defendant. The faxes were substantially similar, inviting Plaintiff to participate in a “nationally recognized, HIPAA-compliant” study by submitting patient information to Defendant online, on an ongoing basis. The faxes indicated that, in return for any patient data Plaintiff submitted, he would receive “points” “toward purchase of a wide variety of gifts from [Defendant’s] on-line catalog,” which included items such as third-party gift cards, event tickets, and merchandise. Prior to receiving the faxes, Plaintiff had no business relationship with Defendant and did not request or consent to receive the faxes.

Plaintiff alleges that Defendant sent the same or similar faxes to thousands of other healthcare providers in violation of the TCPA. Based on these allegations, Plaintiff moves to certify the purported class defined as: All persons: (1) who were sent one or more facsimiles between September 29, 2016 and August 28, 2018, inviting them to participate in Impact Network’s “National Healthcare Census” in exchange for monetary payment; (2) who did not participate in and had never participated in the “National Healthcare Census” survey;

1 The facts are derived from the parties’ statements of facts, briefs, and the exhibits attached thereto. and (3) as to whom Defendant has not produced evidence showing SK&A verified the person’s fax number.

(Pl’s. Mot., ECF 118, at p. 20). LEGAL STANDARD Rule 23 governs the certification of class actions in federal court. A plaintiff seeking class certification must satisfy all four requirements of Rule 23(a). Amgen Inc. v. Conn. Ret. Plans & Tr. Funds, 568 U.S. 455, 460 (2013); see also Marcus v. BMW of N. Am., LLC, 687 F.3d 583, 590 (3d Cir. 2012). These elements are: (1) numerosity — the class is so numerous that joinder of all members is impracticable; (2) commonality — there are questions of law or fact common to the class; (3) typicality — the claims or defenses of the representative parties are typical of the claims or defenses of the class; and (4) adequate representation — the representative parties will fairly and adequately protect the interests of the class. Fed. R. Civ. P. 23(a); see also Marcus, 687 F.3d at 590–91. In addition, a class action plaintiff must also satisfy at least one of the three elements of Rule 23(b)(1), (2), or (3). Fed. R. Civ. P. 23(a)–(b); Wal-Mart Stores, Inc. v. Dukes, 564 U.S. 338, 345 (2011); Marcus, 687 F.3d at 590. Here, Plaintiff proposes his class under Rule 23(b)(3). This Rule permits certification when the court finds that “questions of law or fact common to class members predominate over any questions affecting only individual members” and that “a class action is superior to other available methods for fairly and efficiently adjudicating the controversy.” Fed. R. Civ. P. 23(b)(3). In other

words, Rule 23(b)(3) requires both “predominance” and “superiority.” The United States Court of Appeals for the Third Circuit (the “Third Circuit”) has held that Rule 23(b)(3) also requires that the proposed class be “currently and readily ascertainable based on objective criteria.” In re Niaspan Antitrust Litig., 67 F.4th 118, 129–30 (3d Cir. 2023). Ascertainability is “an essential prerequisite of a class action, at least with respect to actions under Rule 23(b)(3).” Marcus, 687 F.3d at 592–93. As such, “[a] plaintiff seeking certification of a Rule 23(b)(3) class must prove by a preponderance of the evidence that the class is ascertainable.” Byrd v. Aaron’s Inc., 784 F.3d 154, 163 (3d Cir. 2015). The ascertainability requirement is a “threshold issue” and serves several objectives, including “insisting on the easy identification of

class members” and “protect[ing] defendants by ensuring that those persons who will be bound by the final judgment are clearly identifiable.” Marcus, 687 F.3d at 593. “Ascertainability mandates a rigorous approach at the outset because of the key roles it plays as part of a Rule 23(b)(3) class action lawsuit.” Carrera v. Bayer Corp., 727 F.3d 300, 307 (3d Cir. 2013). A “petition for class certification will founder if the only proof of class membership is the say-so of putative class members or if ascertaining the class requires extensive and individualized fact-finding.” Hayes v. Wal-Mart Stores, Inc., 725 F.3d 349, 356 (3d Cir. 2013).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Skidmore v. Swift & Co.
323 U.S. 134 (Supreme Court, 1944)
Russello v. United States
464 U.S. 16 (Supreme Court, 1983)
Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Lamie v. United States Trustee
540 U.S. 526 (Supreme Court, 2004)
Dorothy Allen v. LaSalle Bank
629 F.3d 364 (Third Circuit, 2011)
Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
Marcus v. BMW of North America, LLC
687 F.3d 583 (Third Circuit, 2012)
William Hayes v. WalMart Stores Inc
725 F.3d 349 (Third Circuit, 2013)
Gabriel Carrera v. Bayer Corp
727 F.3d 300 (Third Circuit, 2013)
Alston v. Countrywide Financial Corp.
585 F.3d 753 (Third Circuit, 2009)
In Re Hydrogen Peroxide Antitrust Litigation
552 F.3d 305 (Third Circuit, 2009)
Crystal Byrd v. Aaron's Inc
784 F.3d 154 (Third Circuit, 2015)
United States v. Vernel Williams
917 F.3d 195 (Third Circuit, 2019)
Jarzyna v. Home Properties, L.P.
321 F.R.D. 237 (E.D. Pennsylvania, 2017)
Loper Bright Enterprises v. Raimondo
603 U.S. 369 (Supreme Court, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
FISCHBEIN v. IQVIA, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/fischbein-v-iqvia-inc-paed-2025.